Observational studyNeurocritical care2025
Exploring Cerebrospinal Compensatory Zones Using a Noninvasive Approach.
Observational study in Neurocritical care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT03144219 (A Novel Non-invasive Technique of Cerebral Compliance and Auto-regulation Assessment), which is not on this map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Novel Non-invasive Technique of Cerebral Compliance and Auto-regulation Assessment
Who cites it
7 citing papers in PubMed.
- Intracranial Pressure Estimation Using B4C Device: A Systematic Review on the Validation Studies.Neurocritical care · 2026Review
- Waveform-Derived Metrics of Intracranial Compliance: Validation and Pulsatile Dynamics.Neurocritical care · 2026Article
- Non-invasive intracranial pressure estimation in the intensive care unit: narrative review of methods and clinical applications.Intensive care medicine · 2026Review
- Commentary: Invasive and Noninvasive Intracranial Pressure Pulse Waveform in Neurocritical Care Patients with Different Cranium Integrity.Neurocritical care · 2026Article
- Editorial: Integrative approaches to acute brain injury: vascular, electrical, and metabolic interactions.Frontiers in physiology · 2026Article
- Exploring Cerebrospinal Compensatory Zones Using a Noninvasive Approach.Neurocritical care · 2025Observational
- The dawn of noninvasive intracranial compliance waveforms: a call for the B-ICONIC improvement and expansion.Intensive care medicine · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntracranial compliance (ICC) reflects the balance among intracranial volume components. Recent technological advances enable continuous, noninvasive assessment of ICC in neurocritical care settings. In this study, we aimed to correlate noninvasive ICC parameters derived from intracranial pressure (ICP) waveform morphology with the established amplitude-pressure index (RAP index), which is calculated using invasive ICP monitoring.
methodsPatients with traumatic brain injury underwent ventricular ICP monitoring. Simultaneously, ICP values and waveform characteristics were recorded using an external skull microdynamics sensor (brain4care) that provides surrogate waveform parameters, including the P2/P1 ratio and time-to-peak (TTP). The RAP index was calculated using dedicated software based on ICP values and pulse amplitude and was used to categorize patients into three groups: (1) adequate ICC, (2) compromised ICC, and (3) exhausted ICC. Noninvasive parameters (P2/P1 ratio and TTP) were then analyzed in relation to RAP index groupings.
resultsA total of 61 patients were included. Group 1 (adequate ICC) had a median ICP of 12.3 ± 5.4 mm Hg, a P2/P1 ratio of 1.06 ± 0.3, and a TTP of 0.18 ± 0.09 s. Group 2 (compromised ICC) had a median ICP of 13 ± 6.4 mm Hg, a P2/P1 ratio of 1.15 ± 0.32, and a TTP of 0.23 ± 0.07 s. Group 3 (exhausted ICC) had a median ICP of 19.45 ± 5.9 mm Hg, a P2/P1 ratio of 1.31 ± 0.26, and a TTP of 0.25 ± 0.05 s. Regression analysis revealed a statistically significant association between the noninvasive parameters and RAP index-based ICC classification (p < 0.0001).
conclusionsThis study demonstrates a significant correlation between the RAP index and noninvasive ICP waveform-derived parameters, such as the P2/P1 ratio and TTP. These findings suggest that such noninvasive measures may serve as reliable indicators of ICC status. The critical ICP cut-off per RAP was 19.45 mmHg, below the current threshold for therapy escalation according to TBI guidelines. Although further prospective validation is required, this approach has the potential to facilitate earlier intervention before ICC deterioration and enable noninvasive monitoring, possibly improving outcomes in neurocritical care.
trial registrationNCT03144219. Registered 15 June 2017, http://www. CLINICALTRIALS: gov/NCT03144219 . CLINICAL
trial registrationClinicalTrials.gov identifier: NCT03144219.
Indexed as
Identifiers
40659917What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.